Dexi Chen
Overview
Explore the profile of Dexi Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
158
Citations
2700
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shi H, Wang Q, Liu H, Xu B, Liu Y, Zhao J, et al.
Open Life Sci
. 2024 Nov;
19(1):20220979.
PMID: 39588121
Primary biliary cholangitis (PBC) is an autoimmune liver disease. During the diagnostic process, the patient's autoimmune antibodies are routinely examined. Approximately 20% of PBC patients have positive anti-centromere antibody (ACA)....
2.
Zhang Y, Miao X, Liu F, Shi H, Chen D, Chen Y, et al.
Cell Biol Toxicol
. 2024 Nov;
40(1):102.
PMID: 39576443
The initial stage of alcoholic liver disease (ALD) is hepatic steatosis. Recent studies have highlighted a possible role for Apoptosis-stimulating protein 2 of p53 (ASPP2) in regulating hepatic lipid metabolism...
3.
Guan Y, Li J, Sun B, Xu K, Zhang Y, Ben H, et al.
Int J Biol Macromol
. 2024 Oct;
281(Pt 3):136327.
PMID: 39374711
Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), has a significantly higher risk of recurrence. However, the exact mechanism by which HBV prompts HCC recurrence remains largely unknown. In this study...
4.
Zhang X, Xu L, Fan Z, Gao Y, Tian Y, Cao Y, et al.
Front Immunol
. 2024 Jun;
15:1381735.
PMID: 38840923
Background: Acute liver injury (ALI), which is a type of inflammation-mediated hepatocellular injury, is a clinical syndrome that results from hepatocellular apoptosis and hemorrhagic necrosis. Apoptosis stimulating protein of p53-2...
5.
Wang Q, Tang X, Qiao W, Sun L, Shi H, Chen D, et al.
Microbes Infect
. 2024 May;
26(8):105368.
PMID: 38797428
Background: Primary biliary cholangitis (PBC) is associated closely with the gut microbiota. This study aimed to explore the characteristics of the gut microbiota after the progress of PBC to cirrhosis....
6.
Zhao Y, Yang T, Ouyang Y, Rao W, Liu K, Zheng J, et al.
Front Immunol
. 2024 Feb;
15:1339213.
PMID: 38348038
Background: Radiofrequency ablation (RFA) is the primary curative treatment for hepatocellular carcinoma (HCC) patients who are not eligible for surgery. However, the effects of RFA on the global tumor immune...
7.
Wang X, Yang T, Shi S, Xu C, Wang F, Dai D, et al.
Cancer Med
. 2024 Jan;
13(3):e6736.
PMID: 38204220
Background: The mechanism of decreased T cells infiltrating tumor tissues in hepatocellular carcinoma is poorly understood. Methods: Cells were separated from the single-cell RNA-sequence dataset of hepatocellular carcinoma patients (GSE149614)...
8.
Ning Q, Yang T, Guo X, Huang Y, Gao Y, Liu M, et al.
J Viral Hepat
. 2023 Sep;
30(12):951-958.
PMID: 37735836
The HBV rtA181T mutation is associated with an increased risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). This study aimed to evaluate the mechanism by which...
9.
Li N, Zhu J, Chen P, Bao C, Wang J, Abdelaal T, et al.
Vet Res
. 2023 Sep;
54(1):76.
PMID: 37705063
Due to the increase in bacterial resistance, improving the anti-infectious immunity of the host is rapidly becoming a new strategy for the prevention and treatment of bacterial pneumonia. However, the...
10.
Huo Y, Cao K, Kou B, Chai M, Dou S, Chen D, et al.
Genes Dis
. 2023 Jul;
10(5):1982-1993.
PMID: 37492707
Malignant tumor is still a major problem worldwide. During tumorigenesis or tumor development, tumor suppressor p53-binding protein 2 (TP53BP2), also known as apoptosis stimulating protein 2 of p53 (ASPP2), plays...